Interferon gamma upregulates frataxin and corrects the functional deficits in a Friedreich ataxia model
Barbara Tomassini, Gaetano Arcuri, Silvia Fortuni, Chiranjeevi Sandi, Vahid Ezzatizadeh, Carlo Casali, Ivano Condò, Florence Malisan, Sahar Al-Mahdawi, Mark Pook, Roberto Testi, Barbara Tomassini, Gaetano Arcuri, Silvia Fortuni, Chiranjeevi Sandi, Vahid Ezzatizadeh, Carlo Casali, Ivano Condò, Florence Malisan, Sahar Al-Mahdawi, Mark Pook, Roberto Testi
Abstract
Friedreich's ataxia (FRDA) is the most common hereditary ataxia, affecting ∼3 in 100 000 individuals in Caucasian populations. It is caused by intronic GAA repeat expansions that hinder the expression of the FXN gene, resulting in defective levels of the mitochondrial protein frataxin. Sensory neurons in dorsal root ganglia (DRG) are particularly damaged by frataxin deficiency. There is no specific therapy for FRDA. Here, we show that frataxin levels can be upregulated by interferon gamma (IFNγ) in a variety of cell types, including primary cells derived from FRDA patients. IFNγ appears to act largely through a transcriptional mechanism on the FXN gene. Importantly, in vivo treatment with IFNγ increases frataxin expression in DRG neurons, prevents their pathological changes and ameliorates the sensorimotor performance in FRDA mice. These results disclose new roles for IFNγ in cellular metabolism and have direct implications for the treatment of FRDA.
Figures
References
- Pandolfo M. Friedreich ataxia: the clinical picture. J. Neurol. 2009;256(Suppl. 1):3–8.
- Condò I., Ventura N., Malisan F., Rufini A., Tomassini B., Testi R. In vivo maturation of human frataxin. Hum. Mol. Genet. 2007;16:1534–1540.
- Schmucker S., Argentini M., Carelle-Calmels N., Martelli A., Puccio H. The in vivo mitochondrial two-step maturation of human frataxin. Hum. Mol. Genet. 2008;17:3521–3531.
- Stemmler T.L., Lesuisse E., Pain D., Dancis A. Frataxin and mitochondrial Fe-S cluster biogenesis. J. Biol. Chem. 2010;285:26737–26743.
- Adinolfi S., Iannuzzi C., Prischi F., Pastore C., Iametti S., Martin S.R., Bonomi F., Pastore A. Bacterial frataxin CyaY is the gatekeeper of iron-sulfur cluster formation catalyzed by IscS. Nat. Struct. Mol. Biol. 2009;16:390–396.
- Yoon T., Cowan J.A. Iron-sulfur cluster biosynthesis. Characterization of frataxin as an iron donor for assembly of [2Fe-2S] clusters in ISU-type proteins. J. Am. Chem. Soc. 2003;125:6078–6084.
- Koeppen A.H. Friedreich's ataxia: pathology, pathogenesis, and molecular genetics. J. Neurol. Sci. 2011;303:1–12.
- Marmolino D. Friedreich's ataxia: past, present and future. Brain Res. Rev. 2011;67:311–330.
- Young H.A., Bream J.H. IFN-γ: recent advances in understanding regulation of expression, biological functions, and clinical applications. Curr. Top. Microbiol. Immunol. 2007;316:97–117.
- Strehl B., Seifert U., Kruger E., Heink S., Kuckelkorn U., Kloetzel P.M. Interferon-γ, the functional plasticity of the ubiquitin-proteasome system, and MHC class I antigen processing. Immunol. Rev. 2005;207:19–30.
- Al-Mahdawi S., Pinto R.M., Ismail O., Varshney D., Lymperi S., Sandi C., Trabzuni D., Pook M. The Friedreich ataxia GAA repeat expansion mutation induces comparable epigenetic changes in human and transgenic mouse brain and heart tissues. Hum. Mol. Genet. 2008;17:735–746.
- Al-Mahdawi S., Pinto R.M., Varshney D., Lawrence L., Lowrie M.B., Hughes S., Webster Z., Blake J., Cooper J.M., King R., et al. GAA repeat expansion mutation mouse models of Friedreich ataxia exhibit oxidative stress leading to progressive neuronal and cardiac pathology. Genomics. 2006;88:580–590.
- Sandi C., Pinto R.M., Al-Mahdawi S., Ezzatizadeh V., Barnes G., Jones S., Rusche J.R., Gottesfeld J.M., Pook M.A. Prolonged treatment with pimelic o-aminobenzamide HDAC inhibitors ameliorates the disease phenotype of a Friedreich ataxia mouse model. Neurobiol. Dis. 2011;42:496–505.
- Collins H.L. Withholding iron as a cellular defence mechanism—friend or foe? Eur. J. Immunol. 2008;38:1803–1806.
- Ganz T. Iron in innate immunity: starve the invaders. Curr. Opin. Immunol. 2009;21:63–67.
- Nairz M., Schroll A., Sonnweber T., Weiss G. The struggle for iron—a metal at the host-pathogen interface. Cell Microbiol. 2010;12:1691–1702.
- Byrd T.F., Horwitz M.A. Regulation of transferrin receptor expression and ferritin content in human mononuclear phagocytes. Coordinate upregulation by iron transferrin and downregulation by interferon γ. J. Clin. Invest. 1993;91:969–976.
- Feelders R.A., Vreugdenhil G., Eggermont A.M., Kuiper-Kramer P.A., van Eijk H.G., Swaak A.J. Regulation of iron metabolism in the acute-phase response: interferon γ and tumour necrosis factor alpha induce hypoferraemia, ferritin production and a decrease in circulating transferrin receptors in cancer patients. Eur. J. Clin. Invest. 1998;28:520–527.
- Van Zandt K.E., Sow F.B., Florence W.C., Zwilling B.S., Satoskar A.R., Schlesinger L.S., Lafuse W.P. The iron export protein ferroportin 1 is differentially expressed in mouse macrophage populations and is present in the mycobacterial-containing phagosome. J. Leukoc. Biol. 2008;84:689–700.
- Sow F.B., Florence W.C., Satoskar A.R., Schlesinger L.S., Zwilling B.S., Lafuse W.P. Expression and localization of hepcidin in macrophages: a role in host defense against tuberculosis. J. Leukoc. Biol. 2007;82:934–945.
- Kim S., Ponka P. Effects of interferon-γ and lipopolysaccharide on macrophage iron metabolism are mediated by nitric oxide-induced degradation of iron regulatory protein 2. J. Biol. Chem. 2000;275:6220–6226.
- Alter-Koltunoff M., Goren S., Nousbeck J., Feng C.G., Sher A., Ozato K., Azriel A., Levi B.Z. Innate immunity to intraphagosomal pathogens is mediated by interferon regulatory factor 8 (IRF-8) that stimulates the expression of macrophage-specific Nramp1 through antagonizing repression by c-Myc. J. Biol. Chem. 2008;283:2724–2733.
- Richardson D.R., Huang M.L., Whitnall M., Becker E.M., Ponka P., Rahmanto Y.S. The ins and outs of mitochondrial iron-loading: the metabolic defect in Friedreich's ataxia. J. Mol. Med. 2010;88:323–329.
- Saha B., Jyothi Prasanna S., Chandrasekar B., Nandi D. Gene modulation and immunoregulatory roles of interferon γ. Cytokine. 2010;50:1–14.
- Vanin A.F. Dinitrosyl iron complexes with thiolate ligands: physico-chemistry, biochemistry and physiology. Nitric Oxide. 2009;21:1–13.
- Neumann H., Schmidt H., Wilharm E., Behrens L., Wekerle H. Interferon γ gene expression in sensory neurons: evidence for autocrine gene regulation. J. Exp. Med. 1997;186:2023–2031.
- Jonakait G.M., Wei R., Sheng Z.L., Hart R.P., Ni L. Interferon-γ promotes cholinergic differentiation of embryonic septal nuclei and adjacent basal forebrain. Neuron. 1994;12:1149–1159.
- Rufini A., Fortuni S., Arcuri G., Condo I., Serio D., Incani O., Malisan F., Ventura N., Testi R. Preventing the ubiquitin-proteasome-dependent degradation of frataxin, the protein defective in Friedreich's ataxia. Hum. Mol. Genet. 2011;20:1253–1261.
- Miller C.H., Maher S.G., Young H.A. Clinical use of interferon-γ. Ann. N Y Acad. Sci. 2009;1182:69–79.
Source: PubMed